Natural Cycles, the developer of the world’s first birth control app, has a $55 million Series C funding round to support new product development, healthcare reimbursement automation, and commercial acceleration. The company’s latest round was led by Lauxera Capital Partners, with significant contributions from Point72 Private Investments and a debt facility from J.P Morgan.
Founded in 2013, Natural Cycles developed the industry’s first contraceptive app that seeks to help women plan and control birth naturally. The platform’s algorithm analyses the user’s daily hormone-induced temperature changes to help determine if the user is fertile, helping avoid unintended pregnancies without the use of artificial hormones.
Natural Cycles’ application is the only digital birth control platform so far approved by regulators in Europe, the US, Canada, Australia, South Korea, and Singapore. Earlier last month, the company launched a feature called NC° Postpartum within its application to offer guidance to new mothers recovering from childbirth.
The new feature adds to a host of platform features such as NC° Plan Pregnancy, NC° Follow Pregnancy, and NC° Birth Control, designed to support users in their birth control decision-making throughout their fertility journey.
As part of the investment partnership, Levy will join the company’s Board of Directors, and Lauxera Capital Partners and Point72 Private Investments will join the list of the company’s distinguished investors, including Samsung Ventures, Headline, Heartcore Capital, EQT Ventures, and Bonnier Ventures.
